Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

DIFICID 200 MG TABLET

fidaxomicin
$248.6920per EA

Strength

200 mg/1

Manufacturer

Merck Sharp & Dohme LLC

NDC

52015008001

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

FIDAXOMICIN

Approval Type

New Drug (NDA)

FDA Application

NDA201699

On Market Since

5/27/2011

Pharmacological Classes

Macrolide Antibacterial
Macrolides

Price History

1W

0.0%

1M

+0.0%

3M

-0.0%

6M

-0.0%

1Y

-0.3%

3Y

+10.4%

5Y

+21.7%

All

+72.5%

Generic Alternatives

Save up to 36%

1 alternative • Same active ingredient

FIDAXOMICIN 200 MG TABLET
Generic
00480259634•Teva Pharmaceuticals USA Inc.
$158.6579
Save 36%

Related Drugs

Same classification

ZITHROMAX 250 MG Z-PAK TABLET
Brand
00069306075•Pfizer Inc.
$2.0670
per EA
ZITHROMAX 250 MG TABLET
Brand
00069406101•Pfizer Inc.
$2.0670
per EA
ZITHROMAX 250 MG TABLET
Brand
00069406189•Pfizer Inc.
$2.0670
per EA
E.E.S. 200 MG/5 ML GRANULES
Brand
24338013610•Azurity Pharmaceuticals Inc.
$3.1656
per ML
ERYPED 200 MG/5 ML SUSPENSION
Brand
24338013213•Azurity Pharmaceuticals Inc.
$3.6046
per ML
E.E.S. 200 MG/5 ML SUSPENSION
Brand
24338013402•Azurity Pharmaceuticals Inc.
$3.6046
per ML
E.E.S. 200 MG/5 ML SUSPENSION
Brand
80005015218•Carnegie Pharmaceuticals LLC
$3.6046
per ML
ERYPED 400 MG/5 ML SUSPENSION
Brand
24338013013•Azurity Pharmaceuticals Inc.
$6.3072
per ML
ERYPED 400 MG/5 ML SUSPENSION
Brand
80005015518•Carnegie Pharmaceuticals LLC
$6.3072
per ML
AZASITE 1% EYE DROPS
Brand
82584030703•Thea Pharma Inc.
$98.3418
per ML

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy